Get started
KELLANOVA DRNKELLANOVA DRNKELLANOVA DRN

KELLANOVA DRN

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals Bonds

K1EL34 trade ideas

Mars Acquires Kellanova in $36 Billion Deal: Stock up 7.69% Mars, Inc., the global confectionery giant known for its beloved brands like M&M’s, Snickers, and Twix, has announced its acquisition of Kellanova (NYSE: NYSE:K ), the snack-making powerhouse, for a staggering $35.9 billion. This all-cash deal, which values Kellanova (NYSE: NYSE:K ), at $83.50 per share, represents one of the largest transactions in the food sector in recent history and marks a significant expansion of Mars' footprint in the snacking business. The Rise of Kellanova: A Transformative Journey Kellanova (NYSE: NYSE:K ),, a spin-off from Kellogg’s, has quickly made a name for itself as a dominant player in the snack food market. After its separation from Kellogg’s in 2023, Kellanova (NYSE: NYSE:K ), took control of the company’s high-growth snacking and plant-based brands, leaving the traditional cereal business under the WK Kellogg Co. banner. This strategic move allowed Kellanova (NYSE: NYSE:K ), to focus on expanding its presence in the snacking industry, and the results have been impressive. In 2023, Kellanova (NYSE: NYSE:K ), reported net sales exceeding $13 billion, showcasing the company’s robust growth and market appeal. The acquisition by Mars brings together two giants in the consumer goods industry. Kellanova’s portfolio includes iconic brands such as Pringles, Cheez-It, Pop-Tarts, and RXBar, which have a strong presence in the global snacking market. These brands will now join Mars’ already impressive lineup of products, creating a formidable entity that is well-positioned to dominate the snacking landscape. Mars’ Strategic Move: Expanding in a Competitive Market For Mars, the acquisition of Kellanova (NYSE: NYSE:K ), represents a strategic move to diversify its product offerings and strengthen its position in the snacking sector. The deal comes at a time when the snacking industry is undergoing significant changes, with consumers increasingly seeking convenient and healthier snack options. By bringing Kellanova’s brands into its fold, Mars is poised to meet these evolving consumer preferences head-on. Andrew Clarke, Global President of Mars Snacking, expressed his enthusiasm for the deal, stating, “The Kellanova brands significantly expand our Snacking platform, allowing us to even more effectively meet consumer needs and drive profitable business growth.” This sentiment underscores Mars’ commitment to innovation and growth in the highly competitive snacking market. A 33% Premium: The Financial Details Mars’ offer of $83.50 per share represents a 33% premium over Kellanova’s closing price on August 2, reflecting the high value Mars places on Kellanova’s potential. This premium highlights Mars’ belief in the long-term growth prospects of the combined entity and its confidence in the synergies that will be realized through this acquisition. The $35.9 billion price tag also marks one of the largest deals in the food industry since Kraft merged with Heinz in 2015. It is a testament to the scale and ambition of Mars as it seeks to expand its global presence and capitalize on the booming demand for snacks. The Strategic Impact: Strengthening Mars’ Global Presence The acquisition is expected to close in the first half of 2025, subject to regulatory approvals and Kellanova (NYSE: NYSE:K ) shareholder consent. Upon completion, Kellanova (NYSE: NYSE:K ) will become part of Mars Snacking, a division led by Andrew Clarke and based in Chicago. This integration will create a powerhouse in the snacking industry, combining Mars’ expertise in confectionery with Kellanova’s stronghold in salty snacks and plant-based products. Kellanova’s addition to Mars’ portfolio is anticipated to significantly bolster the company’s presence in the global snacking market. With brands like Pringles and Cheez-It now under its wing, Mars will have a broader range of products to offer consumers, catering to a wide variety of tastes and preferences. This expansion will not only strengthen Mars’ market position but also enhance its ability to compete with other industry giants like Mondelez and PepsiCo. A Timely Acquisition The acquisition comes at a critical time for the U.S. packaged food industry, which has been grappling with slower sales growth amid rising inflation and changing consumer behavior. Many consumers are opting for cheaper private-label products over premium branded items, prompting major players like Kraft Heinz, Mondelez, and Hershey to reassess their strategies. In this challenging environment, Mars’ acquisition of Kellanova (NYSE: NYSE:K ) represents a proactive approach to maintaining and growing its market share. By acquiring Kellanova (NYSE: NYSE:K ), Mars is not only expanding its product offerings but also positioning itself to better navigate the shifting consumer landscape. The combined entity will have the scale and resources to innovate and adapt to changing consumer demands, ensuring that it remains competitive in an increasingly crowded market. Antitrust Considerations: A Clear Path Forward Legal experts have suggested that the Mars-Kellanova deal is unlikely to face significant antitrust hurdles, given the limited overlap between the two companies’ product lines. This assessment is crucial for the smooth progression of the transaction, as it ensures that Mars can swiftly integrate Kellanova’s brands into its operations without facing major regulatory roadblocks. The lack of significant antitrust concerns also highlights the complementary nature of the two companies’ businesses. While Mars is a leader in confectionery, Kellanova’s strength lies in salty snacks and plant-based products. This complementary dynamic will enable Mars to create a more diverse and robust snacking portfolio, further enhancing its competitive edge. A New Era in Snacking As Mars prepares to integrate Kellanova (NYSE: NYSE:K ) into its Snacking division, industry observers are closely watching how the combined entity will leverage its expanded portfolio to drive growth. With Kellanova’s strong brand presence and Mars’ extensive distribution network, the potential for success is substantial. The acquisition also signals a broader trend in the food industry, where mergers and acquisitions are becoming an increasingly important strategy for companies looking to expand their market share and adapt to changing consumer preferences. As the snacking industry continues to evolve, the Mars-Kellanova deal could set the stage for further consolidation and innovation in the sector. Technical Outlook Kellanova (NYSE: NYSE:K ) stock is up 7.66% increase as of the present time, signaling potential for further advancement while also being positioned for heightened volatility. The daily price chart reveals a double gap up pattern, typically associated with strong bullish sentiment or significant news propelling the stock's price higher. This is exemplified by the recent acquisition announcement by Mars Inc. While such gaps can give rise to intensified volatility and reflect investor optimism, they can also instigate uncertainty regarding sustainability. Hence, it is imperative to closely monitor trading volume and market conditions to evaluate the prospects of sustained upward momentum or a potential reversal. In conclusion, Mars’ acquisition of Kellanova is a game-changing move that has the potential to reshape the snacking industry. By bringing together two giants in the consumer goods space, the deal will create a powerful entity capable of meeting the demands of modern consumers and driving significant growth in the years to come. As the industry continues to evolve, Mars and Kellanova’s combined strengths will undoubtedly play a pivotal role in shaping the future of snacking.
NYSE:KLong
by DEXWireNews
Kellanova Stock Jumps 15% On Mars Acquisition in $30 Bln DealThe snacking industry is abuzz with news of a potential mega-deal as Mars, the family-owned candy giant, is in advanced talks to acquire Kellanova (NYSE: NYSE:K ), the maker of beloved brands like Pringles, Cheez-It, and Eggo. According to reports from The Wall Street Journal and Reuters, the deal could be imminent, valuing Kellanova at around $30 billion. This acquisition would be one of the largest in the snacking industry's history, giving Mars a significant boost in the global snacking market. Kellanova, which was spun off from Kellogg last October, has seen its shares rise by around 20% since the separation. However, the company's valuation remains lower than some of its peers, making it an attractive target for acquisition. Mars, which reported a whopping $50 billion in revenue in 2023, is looking to expand its snacking portfolio. The company's snacking division accounted for $18 billion of its total revenue, and the acquisition of Kellanova would further strengthen its position in the market. The potential deal has sent Kellanova's shares soaring, with a 19% jump in premarket trading on Monday. Investors are eager to see the outcome of the talks, which could lead to one of the biggest M&A transactions of the year. While Mars has declined to comment on the reports, Kellanova spokesperson Kris Bahner cited company policy in refusing to comment. However, RBC Capital Markets analyst Nik Modi has upgraded Kellanova shares to outperform, citing the potential deal as a catalyst. The acquisition would also mark a significant shift in the snacking industry, as companies look to consolidate and expand their portfolios in response to slowing organic sales growth. With consumers pulling back on spending, acquisitions have become more attractive, and Mars is poised to make a major move. Technical Outlook At the time of writing, the value of Kellanova shares ( NYSE:K ) has shown a noteworthy 15.4% increase. This upsurge is accompanied by a Bullish Relative Strength Index (RSI) of 87.44, positioning the stock within an overbought region. This suggests that caution should be exercised by traders, as there is a possibility of a potential reversal in the current market trend. Moreover, the daily price chart portrays a gap up pattern, a characteristic observed when a financial instrument's opening price exceeds the closing price of the previous day. This pattern is visually represented on a price chart as an interval where the opening price of a new candle significantly surpasses the closing price and the high of the preceding candle. As the deal inches closer, one thing is clear: the snacking industry will be watching with bated breath as Mars and Kellanova potentially join forces to create a snacking powerhouse.
NYSE:KLong
by DEXWireNews
Kelloggs for Dinner back to the roots in SanatoriumParaphrasing the a prominent Wall Street analyst (1983) which called it "a fine company that's past its prime" and the cereal market was being regarded as "mature". Kelloggs has once more lost its way having underperformed both the leader General Mills #GIS and the broad sector Consumer Staples. Recent suggestions by the CEO that people that can't afford food should have cereal for dinner brings us back to the roots of the company at the Battle Creek Sanitarium's where they fed mentally impaired patients, a wheat-based granola. In my model portfolio Kelloggs is a #SELL possibly a short position against the consumer inflation, and if anything should be reduced to underweight.
SIX:KShort
by edrodven
Kellogg to break to the upside?Kellogg Company - 30d expiry - We look to Buy a break of 62.36 (stop at 59.96) With signals for sentiment at oversold extremes, the dip could not be extended. Bullish divergence is expected to support prices. The bias is to break to the upside. This stock has seen good sales growth. Price action looks to be forming a bottom. Our profit targets will be 68.36 and 70.36 Resistance: 60.37 / 62.18 / 64.00 Support: 58.82 / 57.00 / 55.00 Please be advised that the in formation presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Everest Fortune Group’). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Everest Fortune Group
NYSE:KLong
by VantageMarkets
K is outperforming Mercedes-BenzK (ketamine) will make you almost as smart as me. BENEFITS OF KETAMINE If you’ve ever suffered from any kind of debilitating or chronic condition in your life, you know there are a lot of different medications out there. Some claim to completely cure you, while others merely calm your symptoms. Ketamine is a drug that’s proving to be very successful in treating many different chronic diseases. Ketamine therapy is one of our specialties at Boston MindCare. Our skilled anesthesiologists can help you figure out if this type of therapy is right for you and the condition you’re dealing with. KETAMINE AND YOUR BRAIN Understanding how ketamine works in your brain can help you understand how and why it’s so beneficial for uses other than anesthesia. Ketamine works on a very specific group of cells in your brain called NMDA receptors. These receptors interact with neurotransmitters such as glutamate to rev up your neurons. Most of the time, this is a good thing. However, if your neurons stay in an excitatory state for too long, they begin to die off. This leads to a cascade of events, resulting in certain conditions such as depression or anxiety. These, along with other conditions, have been linked to NMDA receptor malfunction. Ketamine works directly on the brain to block the NMDA receptor signals. This allows the brain to create new pathways and synapses, which can aid the healing of past injury or illness. It also blocks glutamate, which is important for your memory and emotions. This allows you to feel calm and forget the moments before or after surgery. Although this drug is traditionally used for its anesthetic properties, at Boston MindCare, we’ve found that it has many other advantages for a variety of illnesses that may be inpacting your life. THE MANY BENEFITS OF KETAMINE Since ketamine is used for surgery, it helps to calm your mind and also to relieve the pain associated with certain procedures. However, the benefits of ketamine have broken the boundaries of surgery and have shown success in treatment of many conditions, including: Depression Migraines PTSD Chronic pain Obsessive compulsive disorder Bipolar disorder One of the benefits that ketamine offers is a decreased need for narcotic painkillers. This is a great advantage, due to the increased likelihood of tolerance and complications with long-term narcotic use. If you suffer from chronic pain, ketamine may be a great alternative to traditional treatments. Another advantage is that ketamine works very quickly, and continues to work even after it’s metabolized by your body. This is especially true when it’s used for treatment of depression symptoms. Typical antidepressants need weeks to build up in your body and start working, while ketamine can work in a matter of hours. Ketamine, when used properly, also doesn’t have a significant effect on your breathing rate or blood pressure. This makes it very safe for use in surgery, as many other drugs that produce a sedating effect can decrease your blood pressure, which can lead to complications. Although ketamine has shown very positive results for many psychological conditions, it’s not for everybody. It’s important to talk to our staff about all aspects of ketamine therapy, including side effects and contraindications for use. GETTING KETAMINE THERAPY At Boston MindCare, our goal is to help you fight your chronic condition through ketamine infusion therapy. Once our doctors have determined that this type of treatment would be beneficial to you, you’ll make an appointment for your initial infusion. At this appointment, we put an IV line in your arm where the ketamine will be administered. We monitor you the entire time, and one of our anesthesiologists oversees the treatment. Your dose can be adjusted to best suit you and your response to the drug. Most appointments take about an hour or less, depending on how you do and the condition you’re dealing with. There are other forms of ketamine therapy that we offer including: Nasal spray Intramuscular injections Oral medications At your initial appointment, our doctors will discuss which treatment route will be most beneficial in helping you fight your condition. It might be necessary for you to come back for follow-up infusions, but this depends on how you respond to treatment and if your symptoms improve. If you’re at your wits’ end and think ketamine therapy may be the answer you’ve been looking for, call our office at 781-247-5323 to make an appointment or book with us online today.
NYSE:KLong
by Monsieur_Lumberg
Kellogg found a strong support?Kellogg Company - 30d expiry - We look to Buy at 66.71 (stop at 65.04) Levels below 67 continue to attract buyers. Bespoke support is located at 67. 66.45 has been pivotal. Preferred trade is to buy on dips. The primary trend remains bullish. We are trading at oversold extremes. Bullish divergence is expected to support prices. Our profit targets will be 70.88 and 71.88 Resistance: 68.50 / 69.20 / 70.00 Support: 68.00 / 67.00 / 66.45 Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Signal Centre’). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Signal Centre.
NYSE:KLong
by VantageMarkets
K - Cup break upK is a long term investor's dream as the stock continues to be in an bigger uptrend (despite that it has it's fair share of volatility). For the past 2 months, the stock has gone into a cup consolidation and finally broke up last Friday, probably in anticipation of earnngs that is expected out on 3 Nov (BMO). We do not know if this breakup is for real but should there be any near term pullback below the neckline, then I would be watching for a possible "handle" (higher low) which could make the case for a solid cup and handle formation, Disclaimer: Just my 2 cents and not a trade advice. Kindly do your own due diligence and trade according to your own risk tolerance and don't forget that money management is important! Take care and Good Luck!
NYSE:KLong
by Juliac
Kellogg: Company splitting!!Kellogg Company Short Term - We look to Buy at 71.09 (stop at 67.91) This stock has recently been in the news headlines. They are splitting into 3 strategic companies which will increase efficiencies. The stock reacted premarket by breaking out of the triangle formation to the upside. This is positive for sentiment and the uptrend has potential to return. We look to buy dips. Our profit targets will be 81.87 and 84.00 Resistance: 76.00 / 82.00 / 88.00 Support: 70.00 / 66.00 / 60.00 Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Signal Centre’) . Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Signal Centre.
NYSE:KLong
by VantageMarkets